World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
24083
World Ranking
2232
National Ranking
926

Overview

Peter L. Anderson is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily focuses on infectious diseases, especially in the field of HIV/AIDS. They have contributed extensively to areas such as HIV/AIDS research and interventions, treatment development, and the study of related health complications.

The main fields of study associated with Peter L. Anderson include Medicine, with a strong emphasis on subfields such as Infectious Diseases, Virology, and Epidemiology. Their work also intersects with Emergency Medicine and General Health Professions.

Key topics in their research comprise:

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments
  • Adolescent Sexual and Reproductive Health
  • LGBTQ Health, Identity, and Policy

Peter L. Anderson has published notably in several journals, with frequent contributions to:

  • Journal of the International AIDS Society
  • Clinical Infectious Diseases
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • AIDS
  • Open Forum Infectious Diseases

Some of their recent papers include:

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women (2021) published in New England Journal of Medicine
  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022) published in The Lancet
  • Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial (2020) published in The Lancet
  • PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial (2021) published in PLoS Medicine
  • Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions (2020) published in Current HIV/AIDS Reports

Their frequent co-authors include:

  • Lane R. Bushman
  • José Castillo-Mancilla
  • Mark A. Marzinke
  • Samantha MaWhinney
  • Jennifer J. Kiser

Best Publications

  • Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

    Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan

  • Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

    Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu

  • Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

    Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

    Albert Y. Liu;Stephanie E. Cohen;Eric Vittinghoff;Peter L. Anderson

  • Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

    Unknown

  • Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

    Kenneth H Mayer;Kenneth H Mayer;Jean-Michel Molina;Melanie A Thompson;Peter L Anderson

  • Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

    Jose R. Castillo-Mancilla;Jia-Hua Zheng;Joseph E. Rower;Amie Meditz

  • Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.

    Jessica E. Haberer;David R. Bangsberg;Jared M. Baeten;Kathryn Curran

  • Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.

    Peter L. Anderson;Albert Y. Liu;Jose R. Castillo-Mancilla;Edward M. Gardner

  • An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

    Sybil G Hosek;Bret Rudy;Raphael Landovitz;Bill Kapogiannis

  • Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States

    Sybil G. Hosek;Raphael J. Landovitz;Bill Kapogiannis;George K. Siberry

  • The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV‐infected Patients

    JJ Kiser;ML Carten;CL Aquilante;PL Anderson

  • Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection

    Peter L. Anderson;Jennifer J. Kiser;Edward M. Gardner;Joseph E. Rower

  • Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study

    Beatriz Grinsztejn;Brenda Hoagland;Ronaldo I Moreira;Esper G Kallas

  • The Cellular Pharmacology of Nucleoside- and Nucleotide-Analogue Reverse-Transcriptase Inhibitors and Its Relationship to Clinical Toxicities

    Peter L. Anderson;Thomas N. Kakuda;Kenneth A. Lichtenstein

  • Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.

    Edward M Gardner;Edward M Gardner;William J Burman;William J Burman;John F Steiner;Peter L Anderson

  • Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.

    Peter L. Anderson;Jatinder Lamba;Christina L. Aquilante;Erin Schuetz

  • Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)

    Albert Y. Liu;Qiyun Yang;Yong Huang;Peter Bacchetti

  • Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients

    Jennifer J Kiser;Christina L Aquilante;Peter L Anderson;Tracy M King

  • Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

    Kathleen Mulligan;David V. Glidden;Peter L. Anderson;Albert Liu

  • Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)

    Craig W. Hendrix;Adriana Andrade;Namandjé N. Bumpus;Angela D. Kashuba

  • Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.

    Peter L. Anderson;Thomas N. Kakuda;Sagar Kawle;Courtney V. Fletcher

  • Review and management of drug interactions with boceprevir and telaprevir

    Jennifer J. Kiser;James R. Burton;Peter L. Anderson;Gregory T. Everson

Frequent Co-Authors

Robert M. Grant
Robert M. Grant University of California, San Francisco
David V. Glidden
David V. Glidden University of California, San Francisco
Susan Buchbinder
Susan Buchbinder University of California, San Francisco
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
K. Rivet Amico
K. Rivet Amico University of Michigan–Ann Arbor
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
Mauro Schechter
Mauro Schechter Federal University of Rio de Janeiro
Craig M. Wilson
Craig M. Wilson University of Alabama at Birmingham
Courtney V. Fletcher
Courtney V. Fletcher University of Nebraska Medical Center
Esper G. Kallas
Esper G. Kallas Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career pathways. For those interested in healthcare, becoming a functional medicine nurse offers a specialized route that blends biology and patient care, often requiring further nursing qualifications alongside an understanding of microbiological principles.

Additionally, students seeking professions in medical administration or health data management might consider certification as a CPC. This path leverages scientific knowledge within healthcare coding and billing, a growing field with strong job prospects.

It’s also important to highlight that some online degrees are designed with inclusivity in mind. Those with challenging backgrounds can explore options listed under college degrees for felons that provide second chances and pathways toward meaningful careers, including science-related fields.

For graduates interested in child-focused health and development, certifications such as certified child life specialist salary insights reveal promising potential, combining psychology, biology, and patient care—all areas where a microbiology background can be beneficial.

Best Scientists Citing Peter L. Anderson

Trending Scientists